Telemedicine Use and Quality of Opioid Use Disorder Treatment in the US During the COVID-19 Pandemic
Results of a study of 1,768 clinicians treating 11,801 patients with opioid use disorder (OUD), to examine the association between telemedicine adoption during the COVID-19 pandemic and indicators of OUD treatment quality. Explores medications for OUD (MOUD) prescribing and OUD-related clinical events, including drug overdose, inpatient detoxification, and rehabilitation center stay. Features statistics including patient and clinician characteristics, with breakdowns by metropolitan, micropolitan, small town, and rural location.
Ruth Hailu, Ateev Mehrotra, Haiden A. Huskamp, Alisa B. Busch, Michael L. Barnett
JAMA Network Open, 6(1)
Healthcare quality · Infectious diseases · Pharmacy and prescription drugs · Rural-urban differences · Statistics and data · Substance use and misuse · Telehealth